NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,172,044 | +18.6% | 3,821,740 | 0.0% | 0.02% | +20.0% |
| Q1 2023 | $2,675,218 | +37.5% | 3,821,740 | 0.0% | 0.02% | +25.0% |
| Q4 2022 | $1,945,266 | -20.5% | 3,821,740 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $2,446,000 | -37.9% | 3,821,740 | 0.0% | 0.02% | -27.3% |
| Q2 2022 | $3,936,000 | -45.2% | 3,821,740 | 0.0% | 0.02% | -46.3% |
| Q1 2022 | $7,185,000 | -61.0% | 3,821,740 | 0.0% | 0.04% | -54.4% |
| Q4 2021 | $18,421,000 | -33.3% | 3,821,740 | 0.0% | 0.09% | -25.6% |
| Q3 2021 | $27,631,000 | -21.7% | 3,821,740 | 0.0% | 0.12% | -21.9% |
| Q2 2021 | $35,275,000 | -25.0% | 3,821,740 | 0.0% | 0.16% | -24.0% |
| Q1 2021 | $47,046,000 | -12.7% | 3,821,740 | 0.0% | 0.20% | +0.5% |
| Q4 2020 | $53,887,000 | +17.5% | 3,821,740 | 0.0% | 0.20% | +10.9% |
| Q3 2020 | $45,861,000 | -18.7% | 3,821,740 | +12.5% | 0.18% | -26.5% |
| Q2 2020 | $56,402,000 | +45.9% | 3,397,740 | 0.0% | 0.25% | +4.6% |
| Q1 2020 | $38,666,000 | -7.6% | 3,397,740 | 0.0% | 0.24% | +6.7% |
| Q4 2019 | $41,860,000 | +29.9% | 3,397,740 | -69.9% | 0.22% | +1.8% |
| Q3 2019 | $32,221,000 | – | 11,305,679 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,156,200 | $10,672,000 | 1.77% |
| ACT CAPITAL MANAGEMENT, LLC | 239,000 | $2,207,000 | 1.13% |
| EcoR1 Capital, LLC | 2,358,804 | $21,772,000 | 0.81% |
| Redmile Group, LLC | 3,919,235 | $36,175,000 | 0.54% |
| Boxer Capital, LLC | 1,501,058 | $13,855,000 | 0.49% |
| Baker Brothers Advisors | 3,821,740 | $35,275,000 | 0.16% |
| Sio Capital Management, LLC | 38,312 | $354,000 | 0.09% |
| Highland Private Wealth Management | 46,999 | $434,000 | 0.06% |
| PERSONAL CFO SOLUTIONS, LLC | 23,710 | $219,000 | 0.04% |
| Point72 Asset Management, L.P. | 883,102 | $8,151,000 | 0.04% |